Join the Coalition for Global Hepatitis Elimination and ICE-HBV for this webinar on February 1st to dive into the current state of hepatitis D (HDV) elimination. As the world continues to make progress against hepatitis B and hepatitis C, additional research must prioritize estimates of the burden of HDV, improving the quality of HDV diagnostics and therapeutics, and expanding access to HDV screening and treatment.

Program

Chairs

• John Ward, Coalition for Global Hepatitis Elimination, United States
• Maura Dandri, University Medical Center Hamburg-Eppendorf , Germany
• Massimo Levrero, University of Lyon (UCBL1) – Hospices Civils de Lyon and Centre de Recherche en Cancérologie de Lyon (CRCL), France

Presentations

• From Discovery to Current Challenges | Mario Rizzetto, Department of Medical Sciences, University of Turin, Italy
• Virology and Diagnostic Needs | Dieter Glebe, Institute of Medical Virology, National Reference Center for Hepatitis B Viruses and Hepatitis D Viruses, Justus Liebig University Giessen, Germany; German Center for Infection Research, Germany (DZIF)
• Epidemiology and Clinical Features | Pietro Lampertico, Division of Gastroenterology and Hepatology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; CRC “A. M. and A. Migliavacca” Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Italy
• Innovation in Therapy | Marc Bourliere, Department of Hepatology and Gastroenterology, Hôpital Saint-Joseph, France; INSERM UMR1252 IRD SESSTIM sciences économiques et sociales de la santé & traitement de l’information médicale Aix Marseille Université, France

Round Table Discussion with additional invited experts

• Manal El Sayed, Egypt
• Cihan Yurdaydin, Turkey
• Stephan Urban, Germany
• Jeffrey Glenn, United States
• Antonio Bertoletti, Singapore